PAPIVAX BIOTECH INCORPORATED
Booth No: M204
PapiVax Biotech Inc. (PBI) is a Taiwan-based biopharmaceutical corporation that focuses on the development of novel therapeutic vaccines for human papillomavirus (HPV)-associated diseases. The platform technology uses heterologous DNA prime fusion protein or recombinant vaccinia virus boost as a one-two punch to knockout HPV persistent infection, pre-cancerous diseases, and cancers. PBI currently has two phase II clinical products, PVX-2 and PVX-1.
Exhibitors you may be interested in